The mRNA technology has proven both effective and safe so far in the vaccine response to COVID-19, including in response to the virus' variants.
Pharma giant is talking with the UK and other governments about building facilities to bring vaccine development onshore before the next crisis.
Volunteers showed a similar antibody response to people who have recovered from the coronavirus, the companies said in a statement Monday.
Drug firm Sanofi India on Tuesday reported a net profit of Rs 145.9 crore for the March ended quarter.
The price paid by different governments for a vaccine dose - including for the same vaccine - varies across countries, Unicef data shows
Bristol-Myers and Sanofi, which produced Plavix in a partnership, in a joint statement vowed to appeal, saying the decision was "unsupported by the law and at odds with the evidence at trial"
In December last year, Sanofi had said it was targeting "earliest potential approval" of the shot in the second half of 2021, following positive preclinical data
The French company, which stunned investors last year with the delay of a COVID-19 vaccine candidate, confirmed an operating income margin target of 30%
The announcement came as delays or production problems for the Pfizer-BioNTech vaccine and a vaccine from Britain''s AstraZeneca have caused political uproar across the European Union
Drugmakers including Pfizer Inc, Sanofi SA, and GlaxoSmithKline Plc plan to raise US prices on more than 300 drugs in the United States on Jan 1
The two companies said they planned to start another study next February, hoping to come up with a more effective vaccine
In late November, the Sputnik V developers also offered foreign vaccine producers their help
Kiadis owns a platform based on a so-called "allogeneic natural killer" that can seek and identify malignant cancer cells
Analysts see 19 per cent annual growth in earnings during FY20-22 with significant rise in return ratios post sale of a facility
Sanofi and GSK have signed a Statement of Intent with Gavi, a global risk-sharing mechanism for pooled procurement and equitable distribution of eventual Covid-19 vaccines.
The facility is part of COVAX, a coalition of governments, health organisations, businesses and charities working to accelerate the development of Covid-19 vaccines
Boris Johnson earmarks £500 mn for mass rapid testing, Sanofi starts trials of vaccine, Steroids could reduce deaths by a third, and other pandemic-related news across the globe
PARIS (Reuters) - French drugmaker Sanofi and its British peer GSK have started a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical companies race to develop treatments
As US launch of Insulin addresses a large market, improved visibility for more launches will keep sentiment elevated
The company is working on two of the more than 150 potential vaccines being developed across the world to tackle the Covid-19 pandemic